the FDA said the goal of testing will be two-fold: detecting the H5N1 virus and taking the necessary follow-up actions to protect consumers. Raw, unpasteurized milk is a known vector of bird flu ...

In addition to its extensive FDA IND experience with transfection-based lentiviral vector processes, VectorBuilder has established a robust system to adopt advanced technologies, enabling the ...

which is part of British American Tobacco and had sued in 2020 alongside Imperial Brands' subsidiary ITG Brands and Vector Group's Liggett Group unit. R.J. Reynolds and the FDA declined to comment.

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring ... (cannot multiply in human cells) adenoviral vector-based gene therapy. Its safety and efficacy was evaluated ...

Pluristyx, a leading provider of innovative, unmodified, and gene-edited induced pluripotent stem cell (iPSC) lines, submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug Administration ...

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy ...

The FDA argued the law gave it the authority to ... Imperial Brands' (IMB.L), opens new tab subsidiary ITG Brands and Vector Group's Liggett Group unit. R.J. Reynolds and the FDA declined to ...

approval from the U.S. Food and Drug Administration (FDA) on January 11, 2025. VectorBuilder has provided highly customized end-to-end CDMO solutions to support this clinical pipeline.